麻子新
--
Recently, I've seen people discussing the life sciences sector, so I’d like to share my own understanding.
In traditional perception, biotechnology is a huge money burner, with slow R&D and high barriers to entry, quite far from the crypto world. However, what is most valuable in life sciences are data, computing power, and capital flow — which align perfectly with crypto.
Data Rights: Genes, proteins, and medical images will all be assets in the future, and once on-chain, users will control ownership;
DeSci: Research funding flows directly through DAO/token, bypassing opaque institutions;
AI + Pharmaceuticals: AI needs computing power and data, and crypto can incentivize collaboration, making it a natural intersection.
Since we’re discussing this sector, I must mention the token $BIO . Currently, Bio seems to be a leader in the sector. Its fundamentals include:
Token distribution is relatively concentrated, with not much floating supply;
Narrative alignment is high, directly corresponding to the grand story of life sciences;
Exchange resources have clear backing, with signs of support.
This reminds me of the end of the 2021 bull market with BNX. At that time, it was also a new sector (GameFi) strongly promoted by Binance, and everyone thought the hype was cooling down, yet BNX surged from $18 to over $100, accompanying people through the bear market.
Looking at Bio now, the background is similar: backed by Binance, in a new sector, and the trading methods have a bit of BNX flavor. Personally, I even think that BN may hold 60%-80% of the chips (of course, this is just speculation).
That’s why I say, the Bio token has not peaked yet. The life sciences sector is just beginning, and the real climax may still be ahead. $BIO
In traditional perception, biotechnology is a huge money burner, with slow R&D and high barriers to entry, quite far from the crypto world. However, what is most valuable in life sciences are data, computing power, and capital flow — which align perfectly with crypto.
Data Rights: Genes, proteins, and medical images will all be assets in the future, and once on-chain, users will control ownership;
DeSci: Research funding flows directly through DAO/token, bypassing opaque institutions;
AI + Pharmaceuticals: AI needs computing power and data, and crypto can incentivize collaboration, making it a natural intersection.
Since we’re discussing this sector, I must mention the token $BIO . Currently, Bio seems to be a leader in the sector. Its fundamentals include:
Token distribution is relatively concentrated, with not much floating supply;
Narrative alignment is high, directly corresponding to the grand story of life sciences;
Exchange resources have clear backing, with signs of support.
This reminds me of the end of the 2021 bull market with BNX. At that time, it was also a new sector (GameFi) strongly promoted by Binance, and everyone thought the hype was cooling down, yet BNX surged from $18 to over $100, accompanying people through the bear market.
Looking at Bio now, the background is similar: backed by Binance, in a new sector, and the trading methods have a bit of BNX flavor. Personally, I even think that BN may hold 60%-80% of the chips (of course, this is just speculation).
That’s why I say, the Bio token has not peaked yet. The life sciences sector is just beginning, and the real climax may still be ahead. $BIO
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
BIO
0.1971
-1.20%
